Latest News about FDA
Recent news which mentions FDA
FDA Gives Green Signal To Arcellx's Stopped Blood Cancer Study
August 15, 2023
Tickers
ACLX
From Benzinga
Logan Paul Challenges Schumer's Scrutiny Of PRIME's Caffeine Content: 'Why Aren't We Controlling This At The Point Of Purchase?'
August 10, 2023
From Benzinga
Lack Of Oversight Continues To Hurt Hemp Industry, What To Expect From 2023 Farm Bill
August 09, 2023
Tickers
HEMP
From Benzinga
FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
August 07, 2023
From Benzinga
Mesoblast Shares Tumble As FDA Strikes Out Cell Therapy Application For Children Again, Requires Additional Trial
August 04, 2023
Tickers
MESO
From Benzinga
Another Spending Bill Makes Its Way Through Senate, Could Amplify Marijuana & Psychedelics Research
August 03, 2023
From Benzinga
Why Is Regeneron Pharmaceuticals Moving Higher Today?
August 03, 2023
From Benzinga
THC-Based Alzheimer's Trial In Puerto Rico: IGC Pharma Targets Underrepresented Hispanic Communities
August 02, 2023
From Benzinga
Viral On TikTok: This Company's Success Paves Way For Hemp-Based Cannabis Beverages Across State Lines
August 01, 2023
Tickers
HEMP
From Benzinga
Rescheduling Cannabis: What Are The Implications For MSOs, Tax Rule 280E, FDA And Pharma?
August 01, 2023
From Benzinga
GSK's Jemperli Plus Chemo Combo Scores FDA Approval As First New Frontline Treatment For Certain Type Of Endometrial Cancer
August 01, 2023
Tickers
GSK
From Benzinga
DBV Technologies Advances Peanut Allergy Program With FDA Support On Pediatric Studies
August 01, 2023
Tickers
DBVT
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.